Error 404 - Not Found

Suggestions

Merck announces first- quarter 2009 financial results - Merck News Item Apr 21, 2009 The decline in the first quarter gross margin is primarily with the resolution of a previously disclosed investigation by attorneys general from which is expected to occur in the fourth quarter . .. The consolidated 2009 tax rate is estimated to be approximately 21 percent to 24 percent .

Merck Announces Fourth - Quarter and Full-Year 2009 Financial The gross margin was 51.4 percent for the fourth quarter of 2009 and . the fourth quarter of 2009, a 3 percent decline from the same quarter in .. in connection with the resolution of an investigation into whether Merck violated state consumer protection laws with respect to the sales and marketing of VIOXX .

First came Merck's Vioxx , now we have Pfizer warning doctors that It was Pfizer's fourth settlement over illegal marketing activities since 2002. (7/ 21 /09)- Merck & Co. and Schering-Plough Corp. agreed to pay the $5.4 million in .. the drop off in the first quarter of this year may be as large as 30%. This civil settlement ends any investigations into Vioxx advertising

Merck's First Quarter Earnings Per Share Increase 13%; Five Key VIOXX achieved $485 million in sales for the first quarter 2001. . Merck Announces Fourth Quarter 2004 Dividend. An exploratory investigation of the impact of culture on sales force management control systems in Europe. Inc. yesterday reported a 57 percent drop in first-quarter profit , short of Wall

Researchers Expand on Dangers of Vioxx , Drugs in Same Class Merck is reimbursing patients for unused medication. Visit www. vioxx .com to $2.5 billion in sales in 2003 -- about 11 percent of the company's revenue. Merck says it expects earnings per share to fall by as much as 60 cents in the fourth quarter . Learning From Vioxx (The Washington Post , Oct 12, 2004)

GTx ends research partnership with Merck , narrows loss for fourth Mar 15, 2010 Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Financial . including the investigation into the anthrax attacks that killed five Today drugmaker Merck & Co. posted a 12 percent drop in second-quarter profits , Merck & Co. over the fatal effects of its painkiller Vioxx ,

MMP | News INCREASED COSTS RESULT IN DECLINE IN MATSON PROFITS Car volumes were 20 percent lower. Car shipments in the fourth quarter of It may also provide insight to those individuals associated with the investigation of pollution events .. "In regard to refunds, Merck has set up a website at www. vioxx .com where

Merck Announces First- Quarter 2005 Earnings Per Share -EPS- of 62 Posted on: Thursday, 21 April 2005, 09:00 CDT. Merck & Co., Inc. Excluding VIOXX sales in the first quarter of 2004, sales increased 8% during the .. defense costs related to the VIOXX Lawsuits and the VIOXX Investigations . . Bruegger's Enterprises, Inc. Announces 2005 Fourth Quarter and Full Year Sales

Merck & Co., Inc. Q1 2008 Earnings Call Transcript -- Seeking Alpha Apr 21, 2008 Good day, everyone, and welcome to Merck's First Quarter 2008 Earnings ENHANCE trial involving the government investigation , the media attack, . I mean, some ways were blocked as we went through the lot of the VIOXX dynamics. decline ex-US from the fourth quarter to the first quarter.

Celebrex Pharmeceutical Lawsuits Celebrex is in the same class of drugs as the Merck pill Vioxx , . Second- quarter revenue from Celebrex plunged 45 percent to $401 million - one reason the world's . Thursday, April 21 , 2005. Pfizer, the world's largest drug maker, Cox-2 inhibitors had already led to a sales decline in the first quarter .